Sacituzumab govitecan
Sacituzumab govitecan | |
---|---|
Term | Sacituzumab govitecan |
Short definition | Sacituzumab govitecan - (pronounced) (SAK-ih-TOO-zoo-mab GOH-vih-TEE-kan) drug used to treat adults with certain types of urothelial cancer (a type of cancer of the bladder or urinary tract) or breast cancer who have already been treated with other therapies. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Sacituzumab govitecan - (pronounced) (SAK-ih-TOO-zoo-mab GOH-vih-TEE-kan) drug used to treat adults with certain types of urothelial cancer (a type of cancer of the bladder or urinary tract) or breast cancer who have already been treated with other therapies. It is also being studied in the treatment of other types of cancer. Sacituzumab Govitecan contains a monoclonal antibody called sacituzumab that attaches to a protein called TROP2, which is found on some cancer cells. It also contains a cancer drug called SN-38, which can help kill cancer cells. Sacituzumab govitecan is a type of antibody-drug conjugate. Also called Trodelvy
External links
- Medical encyclopedia article on Sacituzumab govitecan
- Wikipedia's article - Sacituzumab govitecan
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski